Frequency-dependent inhibition of neurotransmitter release by besipirdine and HP 184

European Journal of Pharmacology

Volumn 300, Issue 1-2, 1996, Pages 71-74

  Tang, Lei ^a   Kongsamut, Sathapana ^a  

^a SANOFI   (France)

Author keywords

Anticonvulsant; Na+ channel, voltage dependent

Indexed keywords

ANTICONVULSIVE AGENT; BESIPIRDINE; CALCIUM; N (3 FLUORO 4 PYRIDYL) N (3 METHYL 1 INDOLYL)PROPYLAMINE; NERISPIRDINE; NORADRENALIN; POTASSIUM CHLORIDE; RADIOISOTOPE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN SLICE; BRAIN SYNAPTOSOME; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; ELECTRIC POTENTIAL; ELECTROSTIMULATION; FREQUENCY DISCRIMINATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029876176     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00002-7     Document Type: Article

References (14)

1. + channels: local anesthetics, antiarrhythmics and anticonvulsants, Trends Pharmacol. Sci. 8, 57.
2. Comfeldt, M., F, Wirtz-Brugger, M.R. Szewczak, R. Blitzer, E. Landau, V. Haroutunian, R.C. Effland, J.T. Klein and C.P. Smith, 1990, HP 749 (I): a pharmacological profile of a therapeutic agent for Alzheimer's disease, Soc. Neurosci. Abstr. 16, 612.
3. Effland, R.C., J.T. Klein, K.L. Davis and G.E. Olsen, 1990, N-(Pyridinyl)-1 H-indol-1-amines, U.S. Patent No. 4,970,218.
4. Evans, D.A., H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, M.J. Chown, L.E. Hebert, C.H. Hennekens and J.O. Taylor, 1989, Prevalence of Alzheimer's disease in a community of older person, J. Am. Med. Assoc. 262, 2551.
5. Huger, F.P., C.P. Smith, W.W. Petko, P.G. Conway, R.C. Effland and J.T. Klein, 1990, HP749. A potential therapeutic agent for Alzheimer's disease: II. Neurochemical profile, Soc. Neurosci. Abstr. 16, 612.
6. Kongsamut, S. and D.A. Nachshen, 1988, Measurement of the cytosolic sodium ion concentration in rat brain synaptosomes by a fluorescence method, Biochim. Biophys. Acta 940, 241.
7. Santucci, A.S., V. Haroutunian and K.L. Davis, 1991, Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats, Clin. Neuropharmacol. 14 (Suppl. 1), S1.
8. Smith, C.P., L.R. Brougham, F.P. Huger, L. Davis, J.T. Klein and R.C. Effland, 1993, N-(n-Propyl)-N-(3-fluoro-4-pyridinyl)-1 H-3-methylindol-1-amine hydrochloride (HP 184): in vitro spontaneous release of acetylcholine and norepinephrine, Drug Dev. Res. 30, 203.
9. 3H]norepinephrine release from rat cortical slices by N-(n-propyl)-N-(4-pyridinyl)-1 H-indol-1-amine, Drug Dev. Res. 32, 13.
10. Tang, L., C.P. Smith, F.P. Huger and S. Kongsamut, 1995, Besipirdine inhibits effects of veratridine at the voltage-dependent sodium channel, Br. J. Pharmacol. 116, 2468.
11. Wightman, R.M. and J.B. Zimmerman, 1990, Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake, Brain Res. Rev. 15, 135.
12. Willow, M., T. Gonoi and W.A. Catterall, 1985, Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells, Mol. Pharmacol. 27, 549.
13. Zaczek, R., W.J. Tinker, A.R. Logue, G.A. Cain, C.A. Teleha and S.W. Tam, 1993, Effects of linopirdine, HP 749, and glycyl-prolyl-glutamate on transmitter release and uptake, Drug Dev. Res. 29, 203.
14. Zahniser, N.R., J. Peris and L.P. Dwoskin, 1986, Modulation of neurotransmitter release: an assay for receptor function, in: Chemical and Functional Assays of Receptor Binding, Short Course 1 Syllabus, eds. B.J. Hoffer and N.R. Zahniser (Society for Neuroscience, Washington, DC) p. 73.